FDA Panel Addresses Misinformation on Antidepressants and Pregnancy
A recent FDA panel discussion highlights the need to combat misinformation about antidepressants and pregnancy,…
A recent FDA panel discussion highlights the need to combat misinformation about antidepressants and pregnancy,…
A recent FDA panel discussion highlights the need to combat misinformation about antidepressants and pregnancy,…
A recent FDA panel has been accused of promoting misinformation about the use of antidepressants…
A drugmaker has declined an FDA request to pull a treatment from the market after…
The removal of federal restrictions on hemp and CBD products has opened up new opportunities…
The FDA has recalled a popular deodorant brand due to the presence of a known…
The FDA has warned against the use of estrogen therapy for menopause symptoms due to…
A man in New York has died after an MRI machine ripped off his necklace,…
Emord and Verkerk outline a comprehensive plan to challenge FDA censorship and protect health freedom
Reports of nicotine poisoning in children have skyrocketed, prompting the FDA to issue a warning…